HCV Genie V 2.0: A Web 2.0 Interpretation and Analytics Platform for the Versant Hepatitis C Virus (HCV) Genotype Line Probe Assay

被引：0
|
作者：
Dussaq, Alex
Soni, Abha
Willey, Christopher D.
Park, Seung L.
Harada, Shuko
机构：
[1] UAB, Birmingham, AL USA
[2] Community Hlth Syst, Franklin, TN USA
来源：
LABORATORY INVESTIGATION | 2016年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1554
引用
收藏
页码：393A / 393A
页数：1
相关论文
共 50 条
  • [21] Comparison of serum virus load among individuals infected with hepatitis C virus (HCV) by Quantiplex HCV RNA 2.0 and Amplicor HCV Monitor assay.
    Olaso, V
    Cordoba, J
    Lopez, B
    Lainez, B
    Arguello, L
    Eslamdoost, N
    Gobernado, M
    Berenguer, J
    HEPATOLOGY, 1997, 26 (04) : 1789 - 1789
  • [22] Comparative evaluation of the VERSANT HCV RNA 3.0, QUANTIPLEX HCV RNA 2.0, and COBAS AMPLICOR HCV MONITOR version 2.0 assays for quantification of hepatitis C virus RNA in serum (vol 40, pg 495, 2002)
    Germer, JJ
    Heimgartner, PJ
    Ilstrup, DM
    Harmsen, WS
    Jenkins, GD
    Patel, R
    JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (05) : 1885 - 1885
  • [23] Versant HCV Genotype 2.0 assay (LiPA) misclassifies the circulating HCV recombinant RF1_2k/1b in genotype 2 patients
    Orlent, Hans
    Schuermans, Wim
    Padalko, Elizaveta
    Desombere, Isabelle
    Descheemaeker, Patrick
    Van Vlierberghe, Hans
    Reynders, Marijke
    HEPATOLOGY, 2016, 64 : 404A - 404A
  • [24] Performance of the new Bayer VERSANT HCV RNA 3.0 assay for quantitation of hepatitis C virus RNA in plasma and serum: Conversion to international units and comparison with the Roche COBAS amplicor HCV monitor, version 2.0, assay
    Beld, M
    Sentjens, R
    Rebers, S
    Weegink, C
    Weel, J
    Sol, C
    Boom, R
    JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (03) : 788 - 793
  • [25] Identification of two Hepatitis C Virus isolates that failed genotyping by Versant LiPA 2.0 assay
    Molenkamp, Richard
    Harbers, Gonneke
    Schinkel, Janke
    Melchers, Willem J. G.
    JOURNAL OF CLINICAL VIROLOGY, 2009, 44 (03) : 250 - 253
  • [26] Multicenter evaluation of the VERSANT HCV RNA qualitative assay for detection of hepatitis C virus RNA
    Hendricks, DA
    Friesenhahn, M
    Tanimoto, L
    Goergen, B
    Dodge, D
    Comanor, L
    JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (02) : 651 - 656
  • [27] Performance characteristics of the COBAS Amplicor Hepatitis C Virus (HCV) Monitor, version 2.0, international unit assay and the National Genetics Institute HCV Superquant assay
    Konnick, EQ
    Erali, M
    Ashwood, ER
    Hillyard, DR
    JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (03) : 768 - 773
  • [28] Effect of genotypes on the quantification of hepatitis C virus (HCV) RNA in clinical samples using the amplicor HCV monitor test and the quantiplex HCV RNA 2.0 assay (bDNA)
    Tong, CYW
    Hollingsworth, RC
    Williams, H
    Irving, WL
    Gilmore, IT
    JOURNAL OF MEDICAL VIROLOGY, 1998, 55 (03) : 191 - 196
  • [29] Evaluation of the VERSANT HCV RNA 3.0 assay for quantification of hepatitis C virus RNA in serum
    Trimoulet, P
    Halfon, P
    Pohier, E
    Khiri, HN
    Chêne, G
    Fleury, H
    JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (06) : 2031 - 2036
  • [30] Performance evaluation of the DAAN HCV assay for quantification of hepatitis C virus RNA and its comparison with COBAS AmpliPrep/COBAS TaqMan HCV Quantitative Test, v2.0
    He, Yuting
    Wang, Yichong
    Chen, Xuefang
    Huang, Hao
    Deng, Jiankai
    Chen, Peisong
    Bin, Huang
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2020, 34 (07)
12345